Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection.
about
Cytomegalovirus infection in transplant recipientsReal-time PCR in clinical microbiology: applications for routine laboratory testing.A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantationRelationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patientsDefinition of clinical threshold for CMV real-time PCR after comparison with PP65 antigenaemia and clinical data.Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.Human polyomavirus 9 infection in kidney transplant patientsComplete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation.Cytomegalovirus colitis complicating inflammatory bowel disease.Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infantsRapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes.Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients.Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients.Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.Human cytomegalovirus detection by real-time PCR and pp65-antigen test in hematopoietic stem cell transplant recipients: a challenge in low and middle-income countries.Cytomegalovirus infection and the gastrointestinal tract.Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.Clinical characteristics and therapy exploration of active human cytomegalovirus infection in 105 lupus patients.Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence.T and B Cell Markers in Dried Blood Spots of Neonates with Congenital Cytomegalovirus Infection: B Cell Numbers at Birth Are Associated with Long-Term Outcomes.Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.Detection of human cytomegalovirus DNA in various blood components after liver transplantation.Comparison of quantitation of cytomegalovirus DNA by real-time PCR in whole blood with the cytomegalovirus antigenemia assay.Reduced PCR sensitivity due to impaired DNA recovery with the MagNA Pure LC total nucleic acid isolation kitViral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease.Opportunistic virus DNA levels after pediatric stem cell transplantation: serostatus matching, anti-thymocyte globulin, and total body irradiation are additive risk factors.Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation.Prevention of cytomegalovirus reactivaction after allogenic hematopoietic stem cell transplantation with valganciclovir: single center experience.Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients.Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome.Congenital cytomegalovirus infection in the Netherlands: birth prevalence and risk factors.Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation.When are amniotic fluid viral PCR studies indicated in prenatal diagnosis?Impact of congenital cytomegalovirus infection on transcriptomes from archived dried blood spots in relation to long-term clinical outcomeViral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients
P2860
Q26801802-1114568E-3FF1-43E5-A60E-56B8D3CEF9F6Q27472851-945A2BE2-F699-442B-8C90-1DE7DAC97853Q33264234-972A5977-8069-442E-973B-4B2828A4381EQ33307057-495AA01A-E370-4C7E-BD20-B1114A0C2A92Q33526581-A05013DF-3019-4602-8E8D-958319D39F6AQ33591729-B605BA28-13B4-4667-9BC2-5C4CB5F5E141Q33678538-F2F4DB52-45AD-4C44-809E-E381BBAD11A6Q34121789-66BA046E-3B56-4E92-BEC7-73D754D66870Q34572006-9B05439D-7A19-4545-8ED2-AF96BDA4E1C8Q35463640-0A8CEAF2-923E-4056-BD41-79283172E3A3Q35689180-034CC8E0-6784-4F8E-91DD-6BE720039183Q35769567-EEC3E48D-EE0D-4CF7-9500-314D78F8DCA5Q36288594-C485E2C4-214F-4B8D-8264-2CD6B522902FQ36306393-BEA778F3-6658-49E8-923A-410B11319F0AQ36933563-E3767F16-0434-4F17-963A-8ABDE1FF133EQ37284695-E819620A-009F-4A19-BC69-CDE5F51F7659Q37652611-43C7390F-50E6-4510-AAA6-26987773103EQ37726821-141A8C1A-FACB-4335-B6C9-5DFA4FF9DD81Q38010341-89B12342-D028-44E8-A748-7EBF1BBB13CEQ38805253-EBACFAC2-6831-4CB8-99FB-D6F05C45A92FQ40206901-FEF7CEF8-0875-4AE9-BE63-FFE7B26050BDQ40337545-AEC224C9-CE56-47D8-9DA0-5CB1BAE12F98Q40428945-A20AC94A-9C47-4044-8A6F-C161181C6448Q41373726-5A7FC16B-7AC5-472A-978B-C4E97CB505AEQ41479612-18CFD1E1-929A-4134-B789-ECD62D8C0AF5Q41566881-A3FD1E7A-945D-4387-9072-A23641DA4AC8Q41838871-A2A2DDB1-8286-4B9C-AE04-C0456B150E16Q42208965-27DAE096-0240-4BED-86E2-48A7B94A0956Q43468927-7F825492-9652-4325-8868-D827A043306AQ45367721-FE6406C0-1280-47D1-B186-965354ECE8B3Q45416463-ABA2C2A5-51F8-4C35-B974-52C4744E34C7Q46699458-0194F370-6493-4625-815B-51B2A3844CFEQ46963345-DED1C682-FB11-4BD1-9026-CDE5C59EB74CQ47550775-FE6030A6-69FC-48CD-90B7-4F37D95AF8E5Q50433176-A66F43FC-CC8E-4038-83CC-05DAB2FB2B66Q51609961-4FEBE0EC-75A4-41AD-92D4-B5A0ECD2645BQ54327445-971A695E-C695-4844-9BEF-89BCA730D734Q57235744-FF846059-5DED-4C5A-B3C8-8AA5216EEC39Q57235754-F534DF01-124E-4FDF-9195-96627E6FE283
P2860
Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Validation of clinical applica ...... relation to antigen detection.
@en
type
label
Validation of clinical applica ...... relation to antigen detection.
@en
prefLabel
Validation of clinical applica ...... relation to antigen detection.
@en
P2093
P2860
P1476
Validation of clinical applica ...... relation to antigen detection.
@en
P2093
Aloys C M Kroes
Caroline S de Brouwer
Eric C J Claas
Janke Schinkel
Jayant S Kalpoe
Matthias F C Beersma
Menno D de Jong
P2860
P304
P356
10.1128/JCM.42.4.1498-1504.2004
P407
P577
2004-04-01T00:00:00Z